Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing ofPseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance-Reference-Cited by-同舟云学术

Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing ofPseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance

Published:2016-04-26 Issue:8 Volume:71 Page:2218-2229
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:J. Antimicrob. Chemother.

Author:

Walsh Clare C.,Landersdorfer Cornelia B.,McIntosh Michelle P.,Peleg Anton Y.,Hirsch Elizabeth B.,Kirkpatrick Carl M.,Bergen Phillip J.

Funder

Ramaciotti Establishment

Ramaciotti Foundations and a Medical Research and Technology

Victorian College of Pharmacy Foundation Board Cyril Tonkin

Australian National Health and Medical Research Council Career Development

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/71/8/2218/16864059/dkw115.pdf

Reference67 articles.

1. Mermel LA (Clin Infect Dis 2013; 56:123-30)

2. Will new antimicrobials overcome resistance among Gram-negatives?

3. WHO. Antimicrobial Resistance: Global Report on Surveillance 2014. Geneva. http://www.who.int/drugresistance/documents/surveillancereport/en/ .

4. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective

5. Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of fosfomycin in infections caused by multidrug-resistant pathogens, especially pneumonia in children: a five-year retrospective single-centre experience;Journal of Antimicrobial Chemotherapy;2024-07-13

2. In Vitro Antibiofilm Activity of Fosfomycin Alone and in Combination with Other Antibiotics against Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa;Pharmaceuticals;2024-06-12

3. Efficacy of antibiotic combinations in an experimental sepsis model with Pseudomonas aeruginosa;Brazilian Journal of Microbiology;2023-10-13

4. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?;Expert Review of Anti-infective Therapy;2023-03-08

5. In vitro killing of multidrug/extensively drug-resistant Pseudomonas aeruginosa by fosfomycin alone or in combination with antipseudomonal antibiotics;Journal of Chemotherapy;2022-08-09